Stay Informed. Stay Competitive with FREE Insights on the Stock Market, Dow 30 & Emerging Opportunities. Get Free Email Updates

Stay Competitive With Stock Market Updates!

Get Free Updates

Fate Therapeutics to Webcast Conference Call Reporting Q3 2020 Financial Results Nov. 5th At 2 PT

By John F. Heerdink, Jr.

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today announced that the Company will host a conference call and live audio webcast on Thursday, November 5, 2020 at 5:00 p.m. ET to report its third quarter 2020 financial results and provide a corporate update.

In order to participate in the conference call, please dial (877) 303-6235 (domestic) or (631) 291-4837 (international) and refer to conference ID 1060606. To listen only, please dial (877) 638-9571 (domestic) or (760) 666-3586 (international) and refer to conference ID 1060606. The live webcast can be accessed under “Events & Presentations” in the Investors and Media section of the Company’s website at www.fatetherapeutics.com. The archived webcast will be available on the Company’s website beginning approximately two hours after the event.

Post View Count : 707


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us